NCT03576261

Brief Summary

The study aim is to investigate whether preoperative heart failure has impact on hemodynamic stability during anesthesia induction by target controlled infusion of anesthesia (TCI) in non-cardiac, non-morbidly obese surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 3, 2018

Completed
29 days until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2021

Completed
Last Updated

December 16, 2021

Status Verified

December 1, 2021

Enrollment Period

3.3 years

First QC Date

June 4, 2018

Last Update Submit

December 15, 2021

Conditions

Keywords

hemodynamicsvenous returnheart failureanesthesia

Outcome Measures

Primary Outcomes (2)

  • Incidence of blood pressure drops

    Blood pressure drop below mean arterial pressure at 65 mmHg during anesthesia induction. Non-invasive blood pressures (systolic, mean and diastolic) are measured 5 minutes before anesthesia induction and thereafter every 5 minutes post-induction .

    20 minutes post anesthesia induction

  • Incidence of severe blood pressure drops

    Blood pressure drop below mean arterial pressure at 55 mmHg during anesthesia induction. Non-invasive blood pressures (systolic, mean and diastolic) are measured 5 minutes before anesthesia induction and thereafter every 5 minutes post-induction.

    20 minutes post anesthesia induction

Secondary Outcomes (3)

  • Venous return and hemodynamic stability

    20 minutes post anesthesia induction

  • Systolic heart failure and hemodynamic stability

    20 minutes post anesthesia induction

  • Diastolic dysfunction and hemodynamic stability

    20 minutes post anesthesia induction

Study Arms (2)

Preoperative echo + fluids

EXPERIMENTAL

20 individuals investigated by preoperative transthoracic echocardiography. Preoperative colloid fluid bolus (Gelofusine, Fresenius Kabi AB, Sweden) 6 ml/kg lean body weight, is infused intravenously immediately before anesthesia induction.

Other: Preoperative colloid fluid bolus (Gelofusine)Diagnostic Test: Preoperative transthoracic echocardiography

Preoperative echo, control

ACTIVE COMPARATOR

20 individuals investigated by preoperative transthoracic echocardiography. No intravenous fluids are infused before anesthesia induction.

Diagnostic Test: Preoperative transthoracic echocardiography

Interventions

Preoperative colloid fluid bolus

Preoperative echo + fluids

Screening of biventricular systolic and diastolic function of the heart and level of venous return by transthoracic echocardiography approximately one hour before preoperative fluid therapy and anesthesia induction.

Preoperative echo + fluidsPreoperative echo, control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 years
  • body mass index ≤ 35 kg/m2
  • electively scheduled for breast cancer surgery, endocrinologic surgery (thyroid, parathyroid) and general abdominal surgery

You may not qualify if:

  • instable angina pectoris
  • severe bronchial asthma
  • severe COPD
  • dementia
  • severe heart valve disease
  • severe renal failure
  • body mass index \> 35 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunderby teaching hospital

Luleå, 97180, Sweden

Location

MeSH Terms

Conditions

Heart FailureCongenital Abnormalities

Interventions

Polygeline

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

PolymersMacromolecular SubstancesPeptidesAmino Acids, Peptides, and ProteinsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Tomi Myrberg, MD PhD

    Umea Universitet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A consecutive cohort. Signed informed consent is gathered. Non-blinded randomization is conducted to fluid therapy before anesthesia induction. Preoperative diagnostics by echocardiography is conducted to all participants.Two arms, with or without preoperative fluids, are studied regarding hemodynamic stability during anesthesia induction.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 4, 2018

First Posted

July 3, 2018

Study Start

August 1, 2018

Primary Completion

December 1, 2021

Study Completion

December 2, 2021

Last Updated

December 16, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations